Breast cancer susceptibility genes (BRCA1 and BRCA2) pathogenic variants (PVs) are correlated with a substantial elevated lifetime risk of developing breast (BC) and/or ovarian cancer (OC)1–6. This evidence concerns the gene BRCA1 and breast carcinoma.